CURRICULUM VITAE

October, 2018

PERSONAL INFORMATION Born February 8, 1952, Los Angeles, CA US Citizen

EDUCATION Undergraduate 1969-1971 Zoology, Pomona College, Claremont, CA

1971-1973 B.S., Biological Sciences, , Stanford CA

Graduate 1973-1977 M.D., Albert Einstein College of Medicine of Yeshiva University, Bronx, NY

Postgraduate Training 1977-1978 Rotating internship, General , University of California Davis Medical Center, Sacramento, CA

1978-1981 Residency, General Psychiatry, University of California Davis Medical Center, Sacramento, CA

1982-1983 Fellowship, Clinical Research, University of California San Diego, La Jolla, CA

1985-1987 Clinical Associate Physician, General Clinical Research Center, University of New Mexico

HONORS/AWARDS 1973 Departmental Honors, Biological Sciences, Stanford University, Stanford, CA

1977 Alpha Omega Alpha, Albert Einstein College of Medicine, Bronx, NY

1981 Sandoz Outstanding Graduating Resident, University of California Medical Davis Center, Sacramento, CA

1993&1994 Clinical Scientist Award, Clinical Research Center,

1

University of New Mexico School of Medicine

1995 Research Scientist Award, Clinical Research Center, University of New Mexico School of Medicine

LICENSURE AND CERTIFICATION 1984 American Board of Psychiatry and (Psychiatry)

1985- New Mexico Medical License #85-105

ACADEMIC POSITIONS 1983-1984 Clinical Assistant Professor, Assistant Residency Training Director, Department of Psychiatry, University of California Davis Medical Center, Sacramento, CA

1985-1991 Assistant Professor, Department of Psychiatry, University of New Mexico School of Medicine

1991-1995 Associate Professor (tenured), Department of Psychiatry, University of New Mexico School of Medicine

1996-1999 Clinical Associate Professor of Psychiatry, University of British Columbia, Vancouver, BC

2000- Clinical Associate Professor of Psychiatry, University of New Mexico School of Medicine

2008- Associate Research Scientist, Bastyr University, Kenmore WA

CLINICAL POSITIONS 1981-1982 Staff Psychiatrist, Fairbanks Community Mental Health Center, Fairbanks, Alaska

1981-1982 Private Practice, Psychiatry, Fairbanks, Alaska

1985 Chief of Psychiatry, University of New Mexico Cancer Research and Treatment Center

1985 Attending Psychiatrist, Alcoholism Treatment Program, Bernalillo County Mental Health Center, Albuquerque, NM

2 RJ Strassman - CV

1985, 1993-1995 Attending Psychiatrist, Consultation/Liaison Service, University of New Mexico Hospital, Albuquerque, NM

1986-1992 Attending Psychiatrist, Bernalillo County Outpatient Mental Health Clinics, Albuquerque, NM

1996-1997 Staff Psychiatrist, Whatcom Counseling and Psychiatric Clinic, Bellingham, WA

1996-1997 Medical Staff, St. Joseph Hospital, Bellingham, WA

1997-2000 Staff Psychiatrist, Jefferson Mental Health Services, Port Townsend, WA

2000-2004 Private practice of psychiatry, Taos NM

2004-2006 Staff psychiatrist, Presbyterian Medical Services, Gallup, NM

2006-2008 Staff psychiatrist, Ayudantes Inc, Espanola NM

CONSULTING POSITIONS 1985-1995 Medical Consultant, Veterans Administration Hospital, Albuquerque, NM

1985-1995 Medical Expert, Office of Hearing and Appeals, Social Security Administration, Albuquerque, NM

1995-2000 Medical Expert, Office of Hearing and Appeals, Social Security Administration, Seattle, WA

1999-2000 Independent Medical Examiner, CorVel Corporation, Poulsbo, WA

Various times Consultant to National Institute on Drug Abuse, Food and Drug Administration, private industry

ADMINISTRATIVE POSITIONS

3 RJ Strassman - CV

1983-1984 Assistant Residency Training Director, UC Davis Department of Psychiatry

1985-1995 Member, Psychiatry Research Committee, University of New Mexico School of Medicine

1988-1992 Member, Scientific Advisory Committee, General Clinical Research Center, University of New Mexico School of Medicine

1989-1992 Chairman, Scientific Advisory Committee, General Clinical Research Center, University of New Mexico School of Medicine

1994-1995 Chairman, Sabbatical Committee, Department of Psychiatry, University of New Mexico School of Medicine

External dissertation reviewer

2012 Ethan McIlhenny, Louisiana State University, LA. Neuroscience

2018 Rachel Turetzky, Pacifica Graduate Institute, CA. Psychology

PEER REVIEWER Addiction Addiction Research Archives of General Psychiatry Case Reports in Psychiatry European Journal of Clinical Oncology Experimental and Clinical Psychopharmacology Frontiers in Immunology Journal of Clinical Psychopharmacology Journal of Endocrinological Investigation Journal of Nervous and Mental Disease Journal of Pineal Research Journal of Psychedelic Studies Journal of Psychoactive Drugs Journal of Psychopharmacology Journal of Scientific Exploration New England Journal of Medicine Psychoneuroendocrinology

4 RJ Strassman - CV

Therapeutic Advances in Psychopharmacology

ADVISORY PANEL Journal of Drug Education and Awareness

EDITORIAL BOARD Journal of Mindbody States Journal of Psychedelic Studies

GUEST MANAGING EDITOR Frontiers in Pharmacology: Research Topic: “ Research in the 21st Century”; 2017-2018

GRANTS 1985-1986 Principal Investigator, Lynn Pierson Therapeutic and Research Program, (State funded, DEA-, FDA-, NIDA-approved program to provide marijuana/THC to cancer patients for chemotherapy side effects)

1985-1987 Clinical Associate Physician, National Institute of Health, General Clinical Research Center, University of New Mexico School of Medicine, "Human Psychopharmacology of Melatonin," Approximately $130,000 total costs

1989-1990 Principal Investigator, Scottish Rite Foundation for Schizophrenia Research, "Human Psychopharmacology and Neuroendocrinology of N, N-Dimethyltryptamine." Approximately $30,000 total costs

1990-1992 Principal Investigator, National Institute on Drug Abuse, Small Grant (R03) Award, "Human Psychopharmacology and Neuroendocrinology of DMT," Approximately $150,000 total costs

1993-1995 Principal Investigator, National Institute on Drug Abuse, (R01) Award, "Tryptamine : Human ," Approximately $350,000 total costs

PUBLICATIONS Peer-reviewed journal articles

5 RJ Strassman - CV

1. Strassman RJ, Letourneau P, Wessells NK: Elongation of axons in an agar matrix that does not support cell locomotion. Experimental Cell Research 818:482-487, 1973 2. Strassman RJ, Wessells NK: Orientational preferences shown by microspikes of growing nerve cells in vitro. Tissue and Cell 5:412-417, 1973 3. Strassman RJ, Galanter M: The Abhidharma: A cross-cultural application of meditation. International Journal of Social Psychiatry 26:283-290, 1980 4. Risch SC, Janowsky DS, Lisansky EJ, Strassman RJ, Rausch JL, Gillin JC, Judd LL, Huey L: Dexamethasone effects on self-rated mood in depressed inpatients. American Journal of Psychiatry 141:147-148, 1984 5. Strassman RJ: Adverse reactions to psychedelic drugs: A review of the literature. Journal of Nervous and Mental Disease 172:577-595, 1984 6. Strassman R: Light, season, and affective disorders. Western Journal of Medicine 142:678, 1985 7. Kennedy B, Strassman RJ, Ziegler M, Janowsky DS, Risch SC, Huey L, Gillin JC: Cardiovascular, catecholamine and psychological responses to TRH in four types of affective disorder patients. and Metabolic Research 19:164-167, 1987 8. Strassman RJ, Peake GT, Qualls CR, Lisansky EJ: A model for the study of the acute effects of melatonin in man. Journal of Clinical Endocrinology and Metabolism 65:847-852, 1987 9. Rosenthal M, Strassman RJ: Melatonin does not impair corticotropin response of isolated pituitary cells. Neuroendocrinology Letters 10:27-32, 1988 10. Strassman RJ, Peake GT, Qualls CR, Lisansky EJ: Lack of an acute modulatory effect of melatonin on human nocturnal thyrotropin and cortisol secretion. Neuroendocrinology 48:387-393, 1988 11. Strassman RJ, Appenzeller O, Lewy AJ, Qualls CR, Peake GT: Increase in plasma melatonin, beta-endorphin and cortisol after a high-altitude mountain run. Relationship to performance and lack of an effect of naltrexone. Journal of Clinical Endocrinology and Metabolism 69:540-545, 1989 12. Lisansky EJ, Peake GT, Strassman RJ, Qualls CR, Meikle AW, Risch SC, Fava G, Zownir-Brazis M, Hochla P, Britton D: Augmented pituitary corticotropin response to a threshold dosage of human corticotropin-releasing hormone in depressives pre-treated with metyrapone. Archives of General Psychiatry 46:641-649, 1989 13. Strassman RJ, Qualls CR, Lisansky EJ, Peake GT: Sleep deprivation reduces LH secretion independently of melatonin. Acta Endocrinologica 124:646-651, 1991 14. Strassman RJ, Qualls CR, Lisansky EJ, Peake GT: Elevated rectal temperature produced by all night bright light is reversed by melatonin

6 RJ Strassman - CV infusion in men. Journal of Applied Physiology 71:2178-2182, 1991 15. Strassman RJ: Human hallucinogenic drug research in the : A present-day case history and a review of the process. Journal of Psychoactive Drugs 23:29-38, 1991 16. Strassman RJ: Human interactions with drugs affecting serotonergic neurotransmission. Neuropsychopharmacology 7:241-243; 1992 17. Lisansky EJ, Hauger R, Strassman RJ, Dorin R, Meikle AW, Brazis M, Qualls CR, Turkin A. Beta-endorphin response to a low dosage of human corticotropin releasing hormone during metyrapone administration in depression. Endocrinology Research 18:241-260, 1992. 18. Strassman RJ, Qualls CR. Dose-response study of N,N- dimethyltryptamine in humans. I. Neuroendocrine, autonomic and cardiovascular effects. Archives of General Psychiatry. 51:85-97, 1994. 19. Strassman RJ, Qualls CR, Uhlenhuth EH, Kellner R. Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale. Archives of General Psychiatry. 51:98-108, 1994. 20. Strassman RJ. Hallucinogenic drugs in psychiatric research and treatment. Perspectives and prospects. Journal of Nervous and Mental Disease 183:127-138, 1995. 21. Strassman RJ. Human psychopharmacology of N,N- dimethyltryptamine. Behavioral Brain Research 73:121-124, 1996. 22. Grob C, McKenna D, Callaway J, Brito G, Neves E, Oberlaender G, Saide O, Labigalini E, Tacla C, Miranda C, Strassman R, Boone K. Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil. Journal of Nervous and Mental Disease 184: 86-94, 1996 23. Strassman RJ, Qualls C, Berg LM. Differential tolerance development to biological and subjective effects of four closely-spaced administrations of N,N-dimethyltryptamine in humans. Biological Psychiatry 39:784-795, 1996 24. Strassman RJ. Endogenous ketamine-like compounds and the NDE: If so, so what? Journal of Near-Death Studies 16:27-42, 1997 25. Bowdle TA, Radant AD, Cowley DS, Kharasch ED, Strassman RJ, Roy-Byrne PP. Psychedelic effects of ketamine in normal volunteers: Relationship to steady-state plasma concentrations. Anesthesiology 88:82- 88, 1998 26. Riba J, Rodríguez-Fornelis A, Strassman RJ, Barbanoj M J. Psychometric assessment of the Hallucinogen Rating Scale in two different populations of hallucinogen users. Drug and Alcohol Dependence 62:215- 223, 2001 27. Krupitsky EM, Burakov AM, Romanova TN, Grinenko AY, Strassman RJ. Ketamine-assisted psychotherapy (KTP) of heroin addiction: Immediate

7 RJ Strassman - CV effects and six month follow-up. Heffter Review of Psychedelic Research 2:88-101, 2001 28. Krupitsky EM, Burakov AM, Romanova TN, Dunaevksy I, Strassman RJ, Grinenko AY. Ketamine-assisted psychotherapy (KTP) of heroin addiction: Immediate effects and two-year follow-up. Journal of Substance Abuse Treatment 23:273-283, 2002 29. Santos RG, Strassman RJ, Landeira-Fernandez J, Cruz APM. Effects of ayahuasca on psychometric measures of anxiety, panic-like, and hopelessness in Santo Daime members. Journal of Ethnopharmacology 112:507-513, 2007 30. McIlhenny EH, Pipkin KE, Standish LJ, Wechkin HA, Strassman RJ, Barker SA. Direct analysis of psychoactive tryptamine and harmala alkaloids in the Amazonian botanical medicine ayahuasca by liquid chromatography-electrospray ionization-tandem mass spectrometry. Journal of Chromatography A 1216:8960-8968, 2009 31. Barbosa PCR, Cazorla IM, Giglio JS, Strassman RJ. A prospective six-month evaluation of personality traits, psychiatric symptoms, and quality of life in ayahuasca-naïve subjects. Journal of Psychoactive Drugs 41:205- 212, 2009 32. McIlhenny EH, Riba J, Barbanoj MJ, Strassman RJ, Barker SA. Methodology for determining major constituents of ayahuasca and their metabolites in blood. Biomedical Chromatography 25:970-984, 2011 33. McIlhenny EH, Riba J, Barbanoj MJ, Strassman RJ, Barker SA. Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine. Journal of Chromatography B 25:970-984, 2011 34. Mizumoto S, Da Silveira DX, Barbosa PCR, Strassman RJ. Hallucinogen Rating Scale (HRS)- Versão Brasileira: tradução e adaptação transcultural (Hallucinogen Rating Scale [HRS]- A Brazilian version: translation and cross- cultural adaptation). Revista de Psiquiatria Clínica 38: 231-37, 2011 35. Barker SA, McIlhenny EH, Strassman R. A critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955- 2010. Drug Testing and Analysis 4:617-635, 2012 36. Barbosa PCR, Mizumoto S, Bogenschutz MP, Strassman RJ. Health status of ayahuasca users. Drug Testing and Analysis 4:601-609, 2012 37. Barker SA, Borjigin J, Lomnicka I, Strassman R. LC/MS/MS analysis of the endogenous dimethyltryptamine hallucinogens, their precursors, and major metabolites in rat microdialysate. Biomedical Chromatography 27:1690-1700, 2013 38. Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PCR, Strassman RJ. Psilocybin-assisted treatment for alcohol dependence: A

8 RJ Strassman - CV proof of concept study. Journal of Psychopharmacology 29 (3): 289-299, 2015 39. Gallimore A, Strassman R. A model for the application of target- controlled intravenous infusion for a prolonged immersive DMT psychedelic experience. Frontiers in Pharmacology. doi: 10.3389/fphar.2016.00211. 2016 40. Barbosa PCR, Strassman R, da Silveria DX, Areco K, Hoy R, Pommy J, Thoma R, Bogenschutz M. Psychological and neuropsychological assessment of regular hoasca users. Comprehensive Psychiatry 71:95-105, 2016 41. Dean J, Liu T, Huff S, Sheler R, Barker SA, Strassman RJ, Wang M, Borjigin J. Endogenous synthesis and secretion of N,N-dimethyltryptamine (DMT) in mammalian brain: Evidence for increased synthesis in dying rat brain. Submitted

Academic letters, editorials, and comments 1. Santos RG, Strassman RJ: Ayahuasca and psychosis (electronic letter to the editor). British Journal of Psychiatry http://bjp.rcpsych.org/cgi/eletters/190/1/81-a#22556, 2008. 2. Greer G, Strassman RJ: Information on "Ecstasy." (letter) American Journal of Psychiatry 142:1391, 1985 3. Strassman RJ. Comment. Re: Rodriguez M. A Methodology for Studying Various Interpretations of the N,N-dimethyltryptamine-Induced Alternate Reality. Journal of Scientific Exploration 21, 2007. 4. Strassman RJ. Guest opinion. Should we loosen the restrictions on psychedelics? Scientific American, 2018. https://blogs.scientificamerican.com/observations/should-we-loosen-the- restrictions-on-psychedelics/

Filmography Co-producer, DMT, The Spirit Molecule (documentary; Mitch Schultz filmmaker); Warner Bros. Distributing, 2011

Books 1. Strassman RJ. DMT: The Spirit Molecule. Rochester, VT: Park Street Press, 2001 2. Strassman RJ, Wojtowicz S, Luna LE, Frecksa E. Inner Paths to Outer Space. Rochester VT: Park Street Press, 2008 3. Strassman RJ. The Soul of Prophecy. Rochester, VT: Park Street Press, 2014

9 RJ Strassman - CV

Book chapters 1. Lisansky EJ, Strassman RJ, Janowsky DS, Risch SC: Drug-induced psychoses. In: Tupin J, Halbreich U, Pena J (eds) Transient Psychosis: Diagnosis, Management, Evaluation. New York: Bruner/Mazel, 1984, pp. 80-110 2. Strassman RJ. The pineal gland: Current evidence for its role in consciousness. In: Lyttle T (ed) Psychedelic Monographs and Essays. 5, Boynton Beach, FL; 1991, pp 166-205. 3. Strassman RJ. Human hallucinogenic drug research: Regulatory, clinical and scientific issues. In: Lin G, Glennon RA (eds) Hallucinogens: An Update (NIDA Research Monograph 146), 1994, pp 92-123 4. Strassman RJ. Human psychopharmacology of LSD, DMT and related compounds. In: Pletscher A (ed) 50 Years of LSD: State of the Art and Perspectives of Hallucinogens. London: Parthenon, 1994, pp. 145-174 5. Strassman RJ. Biomedical research with psychedelics: Current models and future prospects. In: Forte R (ed) and the Future of Religion. San Francisco: CSP; 1997, pp 153-164 6. Strassman, RJ. Hallucinogens. In: Earleywine M (ed) Subjective Effects of Mind-Altering Drugs. New York: Oxford University Press. 2005, pp. 49-85 7. Labate BC, Santos RG, Strassman RJ, Anderson B, Mizumoto, S. Efectos sobre la dependencia a sustanciasde de la pertenencia a una Iglesia Ayahuasquero Brasilena. In: Labate BC, Bouso JC (eds). Ayahuasca y Salud. Barcelona: Los Libros de la Liebre de Marzo. 2013, pp 302-310 8. Labate BC, Santos RG, Strassman, RJ, Anderson B, Mizumoto S. Effect of Santo Daime membership on substance dependence. In: Labate BC, Bouso JC (eds). The Therapeutic Use of Ayahuasca. New York: Springer. 2013, 153-159 (English translation of #6 (above)) 9. Strassman R. Preparing for the journey. In: Hancock G (ed). The Divine Spark. San Francisco: Red Wheel/Weiser, 2015, 138-162 (reprint of chapter by the same name in Inner Paths to Outer Space [above]).

Lay Publications 1. Strassman RJ, Sitting for sessions: Dharma & DMT research. Tricycle. The Buddhist Review 6:81-88,1996 2. Strassman RJ, Where to with psychedelic research? Asylum (A magazine for democratic psychiatry) 11: 4-6, 1999. 3. Strassman RJ. Forward. In: Dobkin de Rios M, Janiger O LSD, Spirituality, and the Creative Process. Rochester, VT: Park Street Press; 2003, pp. ix-x. 4. Strassman RJ, Creativity and psychedelics. Site Street. Arts and ideas (on-line journal), Spring 2003. http://www.sidestreet.org/sitestreet/index2.html

10 RJ Strassman - CV

5. Strassman RJ. The inner work. The Review 15:77-80, 2006. 6. Strassman RJ. Endogenous hallucinogens and bicamerality. The Jaynesian 3:13-16, 2009. 7. Strassman R. Prophetic state and the DMT effect. Psychedelic Press UK. 5:18-28, 2014. 8. Strassman R. Theoneurology: A New Model for Spiritual Experience. Edge Science 21:7-11, 2015. 9. Strassman R. DMT and the Soul of Prophecy: An excerpt. Dragibus 3:14-18, 2015. 10. Strassman R. Prophetic experience and the DMT effect. Watkins Mind, Body, Spirit 42: 34-36, 2015.

Panels/Symposia 1. American College of Neuropsychopharmacology (1991): Workshop on Human Effects of Melatonin (Alfred J. Lewy, M.D., Ph.D. chair) 2. American Psychiatric Association (1993): Clinical Research with Hallucinogens (Charles Grob, M.D. co-presenter) 3. Serotonin Club (Satellite Meeting of IUPHAR Annual Meeting) (1994): Clinical Research with Hallucinogens (Chair) 4. CINP Annual Meeting (1994): Human Hallucinogen Research (Co- Chair, with Mark A. Geyer, Ph.D.)

Abstracts 1. Strassman R, Peake G, Lisansky E, Uhlenhuth E: Constant nocturnal light suppresses melatonin secretion all night in man. American College of Neuropsychopharmacology Annual Meeting, Washington, DC, 1986 2. Strassman R, Peake G, Lisansky E: A model for the study of melatonin in man: All-night suppression with bright light and subsequent replacement in a physiological range. National Institute of Health General Clinical Research Centers Annual Meeting, Williamsburg, VA, 1987 3. Strassman R, Peake G, Qualls C, Lewy A: Human melatonin: No effect on acute regulation of nocturnal TSH and cortisol secretion. American College of Neuropsychopharmacology Annual Meeting, San Juan, Puerto Rico, 1987 4. Strassman R, Qualls C, Uhlenhuth E, Kellner R: Human psychopharmacology and neuroendocrinology of DMT. American College of Neuropsychopharmacology Annual Meeting, San Juan, Puerto Rico, 1991 5. Strassman R, Qualls C, Uhlenhuth E. Human tolerance studies with the hallucinogen, N,N-dimethyltryptamine. American College of Neuropsychopharmacology, Honolulu, Hawaii, 1993.

Book reviews

11 RJ Strassman - CV

1. Hofmann A: LSD, My Problem Child: Reflections on Sacred Drugs, Mysticism, and Science. Am J Psychiatry 141:1626-1628, 1984 2. Leary T: Flashbacks: An Autobiography. Am J Psychiatry 141:1626-1628, 1984 3. Bakalar J, Grinspoon L: Drug Control in a Free Society. JAMA 254:2974-2975, 1985 4. Grinspoon L, Bakalar J (Eds): Psychedelic Reflections. Am J Psychiatry 143:249-250, 1986 5. Dobkin de Rios M: Hallucinogens: Cross-Cultural Perspectives. Psychiatry 50:90-93, 1987 6. Westermeyer J: A Clinical Guide of Alcohol and Drug Problems. J Clin Psychiatry 48:421, 1987 7. Levy S, Blume S (Eds): Addictions in the Jewish Community. Am J Psychiatry 145:121-122, 1988 8. Herrington R, Jacobson G, Benzer D (Eds): Alcohol and Drug Abuse Handbook. J Clin Psychiatry 49:123-124, 1988 9. Milkman H, Sunderwirth S: Craving for Ecstasy: The Consciousness and Chemistry of Escape. JAMA 259:2614-2615, 1988 10. Hendin H, Haas A, Singer P, Ellner M, Ulman R: Living High: Daily Marijuana Use Among Adults. Am J Psychiatry 145:1467-1468, 1988 11. Fisher S, Raskin A, Uhlenhuth EH (Eds): Cocaine: Clinical and Biobehavioral Aspects. J Clin Psychiatry 49:328, 1988 12. Jacobs MR, Fehr KOB (Eds): Drugs and Drug Abuse, 2nd edition. J Clin Psychiatry 49:375, 1988 13. Levinthal CF: Messengers of Paradise: Opiates and the Brain. JAMA 260:3350-3351, 1988 14. Halaris A: Chronobiology and Psychiatric Disorders. Am J Psychiatry 146:113-114, 1989 15. Lee MA, Shlain B: Acid Dreams. Am J Psychiatry 146:395-396, 1989 16. Stevens J: Storming Heaven. Am J Psychiatry 146:395-396, 1989 17. Nace EP: The Treatment of Alcoholism. J Clin Psychiatry 50:74-75, 1989 18. Frances RJ, Miller SI: Clinical Textbook of Addictive Disorders. J Clin Psychiatry 52:435, 1991 19. Grinspoon L, Bakalar J: Marijuana: Forbidden Medicine. JAMA 270:2878-2879, 1993 20. McKenna T: Food of the Gods. Network (The Scientific and Medical Network Newsletter) 53:58-59, 1994 21. Stafford P: Psychedelics Encyclopedia, 3rd ed. Am J Addict 3:178- 180, 1994 22. Mancall PC: Deadly Medicine: Indians and Alcohol in Early America. JAMA 275:646-647, 1996 23. Zimmer L, Morgan JP: Marijuana Myths, Marijuana facts: A Review

12 RJ Strassman - CV of the Scientific Evidence. JAMA 279:632-633, 1998 24. Grinspoon L, Bakalar JB: Marihuana: Forbidden Medicine (rev. ed.). JAMA 279:963-964, 1998 25. Devereuex P: The Long Trip. Network 69:63-64, 1999 26. Kharitidi O: Entering the Circle. Journal of Scientific Exploration 18:497-500, 2004 27. Richards W. Sacred Knowledge. Journal of Psychedelic Studies, 2018. DOI: 10.1556/2054.2018.003

13 RJ Strassman - CV